Literature DB >> 15299199

Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas.

Koji Takada1, Shozo Yamada, Akira Teramoto.   

Abstract

Angiogenesis generally plays an essential role in tumor growth and metastasis, and also influences the response to treatment in human malignant solid tumors. Even in nonmalignant tumors, angiogenesis is essential for tumor growth and invasion. In order to define the relationship between tumor vascularity and the clinical course in patients with pituitary adenomas, we quantified the vascularity in 47 pituitary adenomas and in 6 normal anterior pituitary glands obtained at autopsy using a computed image-analyzing system. We estimated two parameters, the vascular number and the area as the vascularity. Additionally, we calculated mean individual vessel size using the above two parameters. The relationships of tumor vascularity to clinical, endocrinological and histological findings was assessed. Factors considered included patient age and gender, preoperative medication, histological type, concentration of each hypersecreted pituitary hormone, maximum tumor size, cavernous sinus invasion, intratumoral hemorrhage, and immunohistological results of localization of vascular endothelial growth factor (VEGF). Vascularity was significantly higher in normal glands than in pituitary adenomas. However, there were no significant correlations between tumor vascularity and other clinical, endocrinological, or histological parameters, suggesting that increased angiogenesis is not essential for pituitary adenoma growth or invasiveness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299199     DOI: 10.1385/ep:15:2:131

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  21 in total

1.  Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.

Authors:  P Lohrer; J Gloddek; U Hopfner; M Losa; E Uhl; U Pagotto; G K Stalla; U Renner
Journal:  Neuroendocrinology       Date:  2001-08       Impact factor: 4.914

2.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

3.  Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas.

Authors:  T Iuchi; N Saeki; K Osato; A Yamaura
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

4.  Angiogenesis in pituitary adenomas and the normal pituitary gland.

Authors:  H E Turner; Z Nagy; K C Gatter; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

5.  Prognostic significance of image morphometric microvessel enumeration in breast carcinoma.

Authors:  D W Visscher; S Smilanetz; S Drozdowicz; S M Wykes
Journal:  Anal Quant Cytol Histol       Date:  1993-04       Impact factor: 0.302

6.  Microvasculature of human micro- and macroprolactinomas. A morphological study.

Authors:  A Erroi; M Bassetti; A Spada; G Giannattasio
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

7.  Microvessel quantitation and prognosis in invasive breast carcinoma.

Authors:  S Bosari; A K Lee; R A DeLellis; B D Wiley; G J Heatley; M L Silverman
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

8.  Immunocytochemical Investigations on the Vascularization of Pituitary Adenomas.

Authors:  Marek Pawlikowski; Hanna Pisarek; Maria Jaranowska
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

9.  Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.

Authors:  G Gasparini; P Bevilacqua; E Bonoldi; A Testolin; A Galassi; P Verderio; P Boracchi; R B Guglielmi; F Pezzella
Journal:  Clin Cancer Res       Date:  1995-11       Impact factor: 12.531

10.  Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.

Authors:  B H Bochner; R J Cote; N Weidner; S Groshen; S C Chen; D G Skinner; P W Nichols
Journal:  J Natl Cancer Inst       Date:  1995-11-01       Impact factor: 13.506

View more
  11 in total

1.  VEGF and CD31 association in pituitary adenomas.

Authors:  Carolina Cristina; María Inés Perez-Millan; Guillermina Luque; Raúl Ariel Dulce; Gustavo Sevlever; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas.

Authors:  Jorge Humberto Mukdsi; Ana Lucía De Paul; Silvina Gutiérrez; Félix Daniel Roth; Agustín Aoki; Alicia Inés Torres
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

3.  Characteristics of dynamic magnetic resonance image enhancement in prolactinomas resistant to dopamine agonist therapy.

Authors:  Qinghua Guo; Bradley J Erickson; Alice Y Chang; Dana Erickson
Journal:  J Investig Med       Date:  2015-03       Impact factor: 2.895

4.  Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Authors:  Katsuhiro Miyajima; Susumu Takekoshi; Johbu Itoh; Kochi Kakimoto; Takashi Miyakoshi; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

5.  Microvessel density and area in pituitary microadenomas.

Authors:  Ewa Jasek; Alicja Furgal-Borzych; Grzegorz J Lis; Jan A Litwin; Ewa Rzepecka-Wozniak; Franciszek Trela
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

6.  Cell proliferation, apoptosis, and angiogenesis in non-functional pituitary adenoma: association with tumor invasiveness.

Authors:  Maliheh Ghadir; Mohammad E Khamseh; Mahshid Panahi-Shamsabad; Mohammad Ghorbani; Hamideh Akbari; Ali Zare Mehrjardi; Maryam Honardoost; Bahram Jafar-Mohammadi
Journal:  Endocrine       Date:  2020-07-12       Impact factor: 3.633

7.  TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas.

Authors:  Zhengzheng Xiao; Qin Liu; Feng Mao; Jun Wu; Ting Lei
Journal:  Int J Mol Sci       Date:  2011-06-23       Impact factor: 5.923

Review 8.  Angiogenesis in pituitary adenomas: human studies and new mutant mouse models.

Authors:  Carolina Cristina; Guillermina María Luque; Gianina Demarchi; Felicitas Lopez Vicchi; Lautaro Zubeldia-Brenner; Maria Ines Perez Millan; Sofia Perrone; Ana Maria Ornstein; Isabel M Lacau-Mengido; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Int J Endocrinol       Date:  2014-11-18       Impact factor: 3.257

Review 9.  Molecular Network Basis of Invasive Pituitary Adenoma: A Review.

Authors:  Qi Yang; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-24       Impact factor: 5.555

10.  A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.

Authors:  Yanming Miao; Miao Zong; Tao Jiang; Xuesen Yuan; Shusen Guan; Yisong Wang; Dabiao Zhou
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.